3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
14
Burkitt Lymphoma
10
Lymphoma, Follicular
7
Sarcoma
5
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Hodgkin Disease
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Lymphoma, B-Cell
4
Endometrial Neoplasms
4
Wilms Tumor
3
Triple Negative Breast Neoplasms
3
Sarcoma, Ewing
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Liposarcoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Fallopian Tube Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
trastuzumab biosimilar HLX02
1
Transcutaneous Electric Nerve Stimulation
1
Standard of Care
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Minoxidil
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Disulfides
1
Carboplatin
1
Biopsy
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Doxorubicin
×
30 days
×
Clear all
No trials found.